Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Prostatic NeoplasmsHypogonadismTestosterone Deficiency
Interventions
DRUG

Testosterone gel

Topical gel containing testosterone

DRUG

Placebo

Topical gel without active substance

Trial Locations (10)

Unknown

RECRUITING

Amsterdam UMC location VUmc, Amsterdam

RECRUITING

Netherlands Cancer Institute, Amsterdam

RECRUITING

Rijnstate, Arnhem

RECRUITING

Catharina Hospital, Eindhoven

RECRUITING

Treant, Emmen

RECRUITING

Zuyderland, Heerlen

RECRUITING

St. Antonius Hospital, Nieuwegein

RECRUITING

Radboud university medical center, Nijmegen

RECRUITING

Máxima Medical Centre, Veldhoven

6532 SZ

RECRUITING

Canisius Wilhelmina Ziekenhuis, Nijmegen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Besins Healthcare

INDUSTRY

lead

Canisius-Wilhelmina Hospital

OTHER

NCT04833426 - Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy | Biotech Hunter | Biotech Hunter